Brief: Aroa Biosurgery Says FY23 Product Revenue Guidance Maintained At NZ$51-55 Mln

Aroa Biosurgery

26/07/2022 02:29

July 26 (Reuters) - Aroa Biosurgery Ltd  ARX.AX :
    * FY23 PRODUCT REVENUE GUIDANCE MAINTAINED AT NZ$51-55
MILLION

Source text for Eikon:  ID:nASXXQ0YZ 
Further company coverage:  ARX.AX